Other factors associated with GBM/GSC pathophysiology and heterogeneity may also be regulated by variations in miR-451 levels, including the AMPK-mTOR pathway, 14-3-3 proteins, and the small GTPase, Rac1[4]. The gene discussed is MTOR; the disease is glioblastoma.